This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Oncopeptides Management
Management criteria checks 2/4
Oncopeptides' CEO is Sofia Heigis, appointed in Aug 2023, has a tenure of less than a year. total yearly compensation is SEK3.18M, comprised of 55.3% salary and 44.7% bonuses, including company stock and options. directly owns 0.009% of the company’s shares, worth $4.53K. The average tenure of the management team and the board of directors is 1.5 years and 6.8 years respectively.
Key information
Sofia Heigis
Chief executive officer
SEK 3.2m
Total compensation
CEO salary percentage
55.25%
CEO tenure
less than a year
CEO ownership
0.009%
Management average tenure
1.5yrs
Board average tenure
6.8yrs
Recent management updates
Recent updates
CEO Compensation Analysis
How has Sofia Heigis's remuneration changed compared to Oncopeptides's earnings?
Date
Total Compensation
Salary
Company Earnings
Mar 31 2024
n/a
n/a
-SEK 246m
Dec 31 2023
SEK 3m
SEK 2m
-SEK 249m
Compensation vs Market: Sofia's total compensation ($USD296.89K) is below average for companies of similar size in the US market ($USD670.33K).
Compensation vs Earnings: Insufficient data to compare Sofia's compensation with company performance.
CEO
Sofia Heigis (44 yo)
less than a year
Tenure
SEK 3,180,000
Compensation
Ms. Sofia Heigis, M.sc, was Chief Commercial Officer and Managing Director of Germany at Oncopeptides AB (publ) since 2022 until 07 August 2023 and also serves as its CEO since 07 August 2023. Ms. Heigis j...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Sofia Heigis
Chief Executive Officer
less than a year
SEK 3.18m
0.0093% $ 4.5k
Jakob Lindberg
Chief Scientific Officer
1.5yrs
SEK 4.84m
0.40% $ 195.8k
Rolf Larsson
Founder
no data
no data
no data
Rolf Lewensohn
Founder
no data
no data
no data
Joachim Gullbo
Founder
no data
no data
no data
Kristina Luthman
Founder
no data
no data
no data
Hans Ehrsson
Founder
no data
no data
no data
Peter Nygren
Founder
no data
no data
no data
Henrik Bergentoft
Chief Financial Officer
less than a year
no data
no data
Eva Nordström
COO & Deputy MD
4.5yrs
no data
0.056% $ 27.1k
David Augustsson
Director of IR & Communications
1.5yrs
no data
no data
Sara Svardgren
Head of Human Resources
6.2yrs
no data
0.000040% $ 19.4
1.5yrs
Average Tenure
50yo
Average Age
Experienced Management: ONPP.F's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
Name
Position
Tenure
Compensation
Ownership
Per Wold-Olsen
Independent Chairman of the Board
6.2yrs
SEK 1.63m
0.23% $ 112.2k
Per Anders Samuelsson
Independent Director
12.5yrs
SEK 355.00k
no data
Cecilia Wennborg
Independent Director
7.4yrs
SEK 682.50k
0.026% $ 12.4k
Lori Kunkel
Member of Clinical Advisory Board
no data
no data
no data
Jarl Jungnelius
Independent Director
13.3yrs
SEK 627.50k
0.047% $ 22.8k
Brian Stuglik
Independent Director
6.2yrs
SEK 755.00k
no data
Christian Jacques
Member of Clinical Advisory Board
no data
no data
no data
Jennifer Jackson
Independent Director
5.6yrs
SEK 755.00k
no data
Axel Glasmacher
Member of Clinical Advisory Board
no data
no data
no data
Paul Richardson
Member of Clinical Advisory Board
no data
no data
no data
6.8yrs
Average Tenure
66yo
Average Age
Experienced Board: ONPP.F's board of directors are considered experienced (6.8 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2024/07/31 04:19
End of Day Share Price
2024/05/03 00:00
Earnings
2024/03/31
Annual Earnings
2023/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Oncopeptides AB (publ) is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.